Operating Segments

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Operating Segments

Note 9. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended June 30,
	2019			2018
Revenues
Public Health Solutions	$	1,095,865		$	1,449,044
Specialized BioTherapeutics		449,099			276,501
Total	$	1,544,964		$	1,725,545
Income (Loss) from Operations
Public Health Solutions	$	204,121		$	30,299
Specialized BioTherapeutics		(1,463,334	)		(923,960	)
Corporate		(905,678	)		(695,629	)
Total	$	(2,164,891	)	$	(1,589,290	)
Amortization and Depreciation Expense
Public Health Solutions	$	4,316		$	4,512
Specialized BioTherapeutics		4,168			5,345
Corporate		4,448			1,313
Total	$	12,932		$	11,170
Interest Income, Net
Corporate	$	39,851		$	32,948
Share-Based Compensation
Public Health Solutions	$	8,072		$	12,818
Specialized BioTherapeutics		19,094			21,898
Corporate		45,726			55,709
Total	$	72,892		$	90,425

	Six months Ended June 30,
	2019			2018
Revenues
Public Health Solutions	$	1,776,218		$	2,258,300
Specialized BioTherapeutics		913,534			587,018
Total	$	2,689,752		$	2,845,318
Income/(Loss) from Operations
Public Health Solutions	$	195,110		$	(55,906	)
Specialized BioTherapeutics		(2,798,891	)		(2,445,308	)
Corporate		(1,861,173	)		(1,482,177	)
Total	$	(4,464,954	)	$	(3,983,391	)
Amortization and Depreciation Expense
Public Health Solutions	$	8,718		$	8,992
Specialized BioTherapeutics		8,845			10,729
Corporate		5,429			2,663
Total	$	22,992		$	22,384
Interest Income, Net
Corporate	$	84,604		$	49,843
Share-Based Compensation
Public Health Solutions	$	13,268		$	28,486
Specialized BioTherapeutics		40,002			50,216
Corporate		99,195			119,693
Total	$	152,465		$	198,395

	As of June 30, 2019		As of December 31, 2018
Identifiable Assets
Public Health Solutions	$	1,564,020	$	1,181,114
Specialized BioTherapeutics		150,782		78,336
Corporate		7,478,161		9,232,252
Total	$	9,192,963	$	10,491,702